Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BIOMERICA INCBMRA · Entity 8171 | Director · Chief Financial Officer | January 02, 2020 | January 06, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BIOMERICA INC
Report date January 02, 2020 · Filed January 06, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 101,720 |
Reported balance
After 2020-01-02 transaction · row 1
1 source rowRow 1 · 2020-01-02 · Gift · Disposed 20,000 · Balance 101,720 F1: Stock was a gift - no monetary transaction. |
| Common StockSEC Table I · non-derivative | IndirectTrust | 635,977 |
Reported balance
Holding disclosure · report date 2020-01-02 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 635,977 |
Filing footnotes · ownership attribution and instrument terms
F1: Stock was a gift - no monetary transaction.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2020 Filed Jan 6, 2020 21:44 UTC | BIOMERICA INC BMRA · Entity 8171 | GiftCommon Stock | 20,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001513162-20-000002 · primary_doc.xml · nonDerivative · entry 1 MOORE JANET · CIK 0001069306 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,720 F1 · price: Stock was a gift - no monetary transaction. Read SEC document |
| December 19, 2019 Filed Dec 23, 2019 20:53 UTC | BIOMERICA INC BMRA · Entity 8171 | GrantNon Qualified Stock Option · Derivative | 30,000 | Not disclosed Strike: $2.81 | Not disclosed |
DisclosureSEC source: 0001513162-19-000256 · primary_doc.xml · derivative · entry 3 MOORE JANET · CIK 0001069306 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,000 Underlying: Common Stock · 30,000 shares Expires 2029-12-20 F2 · price: Not applicable. F1 · derivative.exercise_date: Vests one-quarter 12/20/20 and one-quarter on Dec 20 each year thereafter. Read SEC document |
| October 28, 2019 Filed Oct 30, 2019 20:39 UTC | BIOMERICA INC BMRA · Entity 8171 | GiftCommon Stock | 3,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001513162-19-000228 · primary_doc.xml · nonDerivative · entry 1 MOORE JANET · CIK 0001069306 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,720 F1 · price: Stock was a gift - no monetary transaction. Read SEC document |
| April 23, 2019 Filed Apr 25, 2019 20:13 UTC | BIOMERICA INC BMRA · Entity 8171 | GiftCommon Stock | 16,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001513162-19-000112 · primary_doc.xml · nonDerivative · entry 1 MOORE JANET · CIK 0001069306 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,720 F1 · price: Stock was a gift - no monetary transaction. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 23:55 UTC | BIOMERICA INC BMRA · Entity 8171 | GrantNon Qualified Stock Option · Derivative | 35,000 | Not disclosed Strike: $2.25 | Not disclosed |
DisclosureSEC source: 0001513162-18-000325 · primary_doc.xml · derivative · entry 3 MOORE JANET · CIK 0001069306 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,000 Underlying: Common Stock · 35,000 shares Expires 2028-12-20 F2 · price: Not applicable F1 · derivative.exercise_date: Vests one-quarter 12/20/2019 and one-quarter on Dec 20 each year thereafter. Read SEC document |
| January 22, 2018 Filed Jan 25, 2018 01:41 UTC Amendment | BIOMERICA INC BMRA · Entity 8171 | GrantNon qualified stock option · Derivative | 25,000 | Not disclosed Strike: $3.90 | Not disclosed |
DisclosureSEC source: 0001513162-18-000030 · primary_doc.xml · derivative · entry 1 MOORE JANET · CIK 0001069306 · Director · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,000 Underlying: Common Stock · 25,000 shares Expires 2028-01-22 F2 · price: Inapplicable. F1 · derivative.exercise_date: Vests one-third on 01/22/2019 and one-third on January 22nd each year thereafter. Read SEC document |
| January 22, 2018 Filed Jan 24, 2018 22:11 UTC | BIOMERICA INC BMRA · Entity 8171 | GrantNon qualified stock option · Derivative | 25,000 | Not disclosed Strike: $3.90 | Not disclosed |
DisclosureSEC source: 0001513162-18-000023 · primary_doc.xml · derivative · entry 3 MOORE JANET · CIK 0001069306 · Director · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,000 Underlying: Common Stock · 25,000 shares Expires 2018-01-22 F2 · price: Inapplicable. F1 · derivative.exercise_date: Vests one-third on 01/22/2019 and one-third on January 22nd each year thereafter. Read SEC document |
| January 04, 2017 Filed Jan 4, 2017 21:46 UTC | BIOMERICA INC BMRA · Entity 8171 | OtherNon-qualified stock option · Derivative | 9,000 | Not disclosed Strike: $0.43 | Not disclosed |
DisclosureSEC source: 0001513162-17-000005 · primary_doc.xml · derivative · entry 4 MOORE JANET · CIK 0001069306 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 9,000 shares Expires 2017-01-05 F1 · price: Consists of various options with varying dates and prices, both expiring and exercisable Read SEC document |
| January 04, 2017 Filed Jan 4, 2017 21:46 UTC | BIOMERICA INC BMRA · Entity 8171 | SaleCommon Stock | 4,500 | $2.20 | $9,887.85 |
DisclosureSEC source: 0001513162-17-000005 · primary_doc.xml · nonDerivative · entry 2 MOORE JANET · CIK 0001069306 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,720 Read SEC document |
| January 04, 2017 Filed Jan 4, 2017 21:46 UTC | BIOMERICA INC BMRA · Entity 8171 | Exercise / conversionCommon Stock | 9,000 | $0.43 | $3,870.00 |
DisclosureSEC source: 0001513162-17-000005 · primary_doc.xml · nonDerivative · entry 1 MOORE JANET · CIK 0001069306 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,220 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 30, 2016 Filed Jan 3, 2017 20:19 UTC | BIOMERICA INC BMRA · Entity 8171 | OtherNon-qualified stock option · Derivative | 3,000 | Not disclosed Strike: $0.43 | Not disclosed |
DisclosureSEC source: 0001513162-17-000002 · primary_doc.xml · derivative · entry 3 MOORE JANET · CIK 0001069306 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,000 Underlying: Common Stock · 3,000 shares Expires 2017-01-05 F1 · price: Consists of various options reported previously with varying dates and prices, both expiring and exercisable Read SEC document |
| December 30, 2016 Filed Jan 3, 2017 20:19 UTC | BIOMERICA INC BMRA · Entity 8171 | Exercise / conversionCommon Stock | 3,000 | $0.43 | $1,290.00 |
DisclosureSEC source: 0001513162-17-000002 · primary_doc.xml · nonDerivative · entry 1 MOORE JANET · CIK 0001069306 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,220 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 23, 2016 Filed Dec 23, 2016 21:35 UTC | BIOMERICA INC BMRA · Entity 8171 | OtherNon-qualified stock option · Derivative | 21,000 | Not disclosed Strike: $0.43 | Not disclosed |
DisclosureSEC source: 0001513162-16-001116 · primary_doc.xml · derivative · entry 5 MOORE JANET · CIK 0001069306 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,000 Underlying: Common Stock · 21,000 shares Expires 2017-01-05 F1 · price: Consists of various options reported previously with varying dates and prices, both expiring and exercisable Read SEC document |
| December 22, 2016 Filed Dec 23, 2016 21:35 UTC | BIOMERICA INC BMRA · Entity 8171 | SaleCommon Stock | 180 | $2.20 | $396.00 |
DisclosureSEC source: 0001513162-16-001116 · primary_doc.xml · nonDerivative · entry 3 MOORE JANET · CIK 0001069306 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,220 Read SEC document |
| December 22, 2016 Filed Jan 3, 2017 19:29 UTC Amendment | BIOMERICA INC BMRA · Entity 8171 | SaleCommon Stock | 180 | $2.20 | $396.00 |
DisclosureSEC source: 0001513162-17-000001 · primary_doc.xml · nonDerivative · entry 3 MOORE JANET · CIK 0001069306 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,220 Read SEC document |
| December 21, 2016 Filed Dec 23, 2016 21:35 UTC | BIOMERICA INC BMRA · Entity 8171 | SaleCommon Stock | 9,600 | $2.18 | $20,941.44 |
DisclosureSEC source: 0001513162-16-001116 · primary_doc.xml · nonDerivative · entry 2 MOORE JANET · CIK 0001069306 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,400 Read SEC document |
| December 21, 2016 Filed Dec 23, 2016 21:35 UTC | BIOMERICA INC BMRA · Entity 8171 | Exercise / conversionCommon Stock | 21,000 | $0.43 | $9,030.00 |
DisclosureSEC source: 0001513162-16-001116 · primary_doc.xml · nonDerivative · entry 1 MOORE JANET · CIK 0001069306 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 21, 2016 Filed Jan 3, 2017 19:29 UTC Amendment | BIOMERICA INC BMRA · Entity 8171 | OtherNon-qualified stock option · Derivative | 22,000 | Not disclosed Strike: $0.43 | Not disclosed |
DisclosureSEC source: 0001513162-17-000001 · primary_doc.xml · derivative · entry 5 MOORE JANET · CIK 0001069306 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,000 Underlying: Common Stock · 22,000 shares Expires 2017-01-05 F1 · price: Consists of various options reported previously with varying dates and prices, both expiring and exercisable Read SEC document |
| December 21, 2016 Filed Jan 3, 2017 19:29 UTC Amendment | BIOMERICA INC BMRA · Entity 8171 | SaleCommon Stock | 9,600 | $2.18 | $20,941.44 |
DisclosureSEC source: 0001513162-17-000001 · primary_doc.xml · nonDerivative · entry 2 MOORE JANET · CIK 0001069306 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,400 Read SEC document |
| December 21, 2016 Filed Jan 3, 2017 19:29 UTC Amendment | BIOMERICA INC BMRA · Entity 8171 | Exercise / conversionCommon Stock | 22,000 | $0.43 | $9,460.00 |
DisclosureSEC source: 0001513162-17-000001 · primary_doc.xml · nonDerivative · entry 1 MOORE JANET · CIK 0001069306 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.